Status:
WITHDRAWN
Mycophenolate Mofetil Maintenance Therapy for Liver Transplantation
Lead Sponsor:
University of Wisconsin, Madison
Conditions:
Primary Liver Transplant
Eligibility:
All Genders
45+ years
Phase:
NA
Brief Summary
The rationale for this study is to determine if Campath-1H can be used in liver transplant recipients to induce a state of immunological unresponsiveness that would not only eliminate the need for cal...
Eligibility Criteria
Inclusion
- Male or female subjects;
- Ages 45 years and older;
- Are to receive a liver transplant.
Exclusion
- Recipients of a multi-organ transplant;
- known hypersensitivity to daclizumab, CellCept®, or prednisone;
- therapy with an investigational medication within 4 weeks of study entry;
- history of malignancies within the past 5 years and/or lymphoma, excluding adequately treated skin carcinoma (basal or squamous cell), or other than exclusion #9;
- history of a psychological illness or condition such as to interfere with the patient's ability to understand the requirements of the study;
- history of HIV infection;
- females who are pregnant or nursing;
- subject is receiving systemic corticosteroids for other medical conditions for which the physician feels that discontinuation of corticosteroids is contraindicated;
- T2 or higher hepatocellular carcinoma
Key Trial Info
Start Date :
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00849238
Last Update
October 8 2015
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.